All
Allergan set to unveil eyelash-growing product
June 12th 2008Irvine, Calif. - Allergan is planning to file a New Drug Application to the FDA by end of the third quarter of 2008 for bimatoprost, a synthetic prostaglandin analog, as a treatment to stimulate eyelash growth, according to a press release.
Study finds less dermatitis with IMRT therapy in breast cancer
June 3rd 2008Toronto - A Canadian research team reports that intensity-modulated radiation therapy (IMRT) reduces the incidence of radiation-induced dermatitis, compared to conventional radiation, in women being treated for breast cancer, according to Reuters Health.
Medicis recalls certain lots of Solodyn tablets
June 3rd 2008Scottsdale, Ariz. - Medicis Pharmaceutical has issued a statement announcing its voluntary recall of lot numbers B080037 and B080038 of the antibiotic Solodyn Extended Release Tablets, 90 mg, 30-count bottles, both of which carry an expiration date of December 2009.
The essential financial contract: Early planning, negotiation save headaches later on
June 1st 2008As with any legal or insurance planning, the early bird is richly rewarded. Nowhere in practice planning is this truer than in the Buy-Sell agreement. The reason is not so much economic, but political. If this planning is done before any owner is close to a disability, divorce, retirement, or death, all owners are in the same position relative to each other. That makes the negotiation of a standard deal for all owners a much easier and smoother process. Planning early for a Buy-Sell agreement will truly benefit you, your family and your practice.
Under the sun: Pendulum may be swinging toward less conservative view of vitamin D issue
June 1st 2008The results of recent studies on the value of Vitamin D in warding off serious illnesses are fueling the ongoing debate over the dermatologic community's "official" stance that warns against the dangers of sunlight, from which the body most efficiently acquires Vitamin D.
Skincare in the outback: Primary clinics in Australia raise concerns
June 1st 2008In Australia, GPs and other non-specialists are effective in taking the heavy burden off the shoulders of dermatologists by sharing the work in seeing skin cancer patients. The problem is that some of these physicians lack special training and therefore c
Following up: PMMA filler shows five-year safety, efficacy
June 1st 2008A retrospective five-year safety and efficacy study of a new PMMA filler shows a low risk of adverse events and a trend toward continued improvement over the entire five-year follow-up period, says a researcher involved with the study.